Home » Topics » Regulatory » Patents

Patents
RSS

Microcide reveals new cephalosporins active against resistant organisms

May 27, 1997

Short-acting beta1-adrenoceptor blockers from U. of Melbourne

May 27, 1997

ET antagonists disclosed by Merck KGaA

May 27, 1997

Glaxo Wellcome discloses heteroaromatic protein tyrosine kinase inhibitors

May 27, 1997

Pyrimidine derivatives from Roche for psychotic disorders

May 26, 1997

5-HT reuptake inhibitors disclosed by NeuroSearch

May 26, 1997

MAO-A and/or MAO-B inhibitors described by Synthelabo

May 26, 1997

EAA antagonists reported by Pharmacia & Upjohn

May 26, 1997

Chem. Pharm. Forschungs-Gesellschaft describes COX-2 inhibitors

May 26, 1997

Lilly describes new agents for postmenopausal syndrome

May 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...